WHO to Endorse Triple-Dose Anti-HIV Generics
The endorsement is seen as controversial, since a distribution of generic drugs could violate a variety of patents, according to the newspaper.
One generic combination drug is already is being sold by an Indian company, and several others are in the pipeline, the newspaper reported.
WHO officials and AIDS groups have been negotiating with the companies...
To view the full article, register now.